{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:10:13Z","timestamp":1789139413110,"version":"build-2803163510"},"reference-count":49,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM109835"],"award-info":[{"award-number":["T32 GM109835"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F30AG082406"],"award-info":[{"award-number":["F30AG082406"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG008017"],"award-info":[{"award-number":["P30AG008017"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG066518"],"award-info":[{"award-number":["P30AG066518"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002369"],"award-info":[{"award-number":["UL1TR002369"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    Heterozygote carriers of Gaucher's disease mutations and other polymorphisms in the glucocerebrosidase (GBA) gene show an increased incidence of Parkinson's disease. We hypothesized that common\n                    <jats:italic toggle=\"yes\">GBA<\/jats:italic>\n                    polymorphisms would be associated with subtle parkinsonian features, mild cognitive impairment, and \u201csilent\u201d Lewy body (LB) pathology in aging individuals without a clinical diagnosis of parkinsonism. The most prevalent\n                    <jats:italic toggle=\"yes\">GBA<\/jats:italic>\n                    variants, T369M and E326K, appear in the general population at rates of approximately 0.6% and 1%, respectively. We evaluated 845 participants from the Oregon Alzheimer's Disease Research Center (OADRC) with SNP data generated by the National Centralized Repository of Alzheimer's Disease (NCRAD). Twenty-one subjects were E326K carriers and eighteen were T369M carriers. Clinical measures and postmortem neuropathology were compared between each SNP group and non-carriers. Although there were no statistically significant clinical differences related to synucleinopathy across groups, neuropathological analyses revealed a significantly higher prevalence of LB pathology in E326K carriers compared to T369M carriers. When stratifying each genetic group by LB status (LB+ or LB\u2212), LB+ E326K carriers demonstrated a significant reduction in Mini-Mental State Examination (MMSE) scores compared with LB\u2212 non-carriers and a modest decrease compared with T369M carriers. These preliminary findings from a small, uni-center cohort suggest that the E326K\n                    <jats:italic toggle=\"yes\">GBA<\/jats:italic>\n                    polymorphism may predict LB pathology and subtle cognitive decline in aging individuals who lack overt parkinsonian symptoms. Further validation in a larger cohort is warranted. Identifying at-risk individuals through targeted genetic screening may ultimately support earlier intervention and preventative care strategies.\n                  <\/jats:p>","DOI":"10.1177\/1877718x261468542","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:16:47Z","timestamp":1784729807000},"page":"1137-1149","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["E326K\n                    <i>GBA<\/i>\n                    polymorphism is associated with clinical and pathological features of synucleinopathy in the absence of overt Parkinson's disease or Lewy body dementia"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-7978","authenticated-orcid":false,"given":"Moriah R.","family":"Arnold","sequence":"first","affiliation":[{"name":"Oregon Health and Science University"},{"name":"Department of Neurology, Oregon Health and Science University, Portland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4128-0451","authenticated-orcid":false,"given":"Shawn K.","family":"Westaway","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oregon Health and Science University, Portland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0755-9846","authenticated-orcid":false,"given":"Randy L.","family":"Woltjer","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-859X","authenticated-orcid":false,"given":"Nora E.","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oregon Health and Science University, Portland, USA"},{"name":"Parkinson\u2019s Disease Research Education and Clinical Care Center, Portland VA Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7305-2256","authenticated-orcid":false,"given":"Joseph F.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oregon Health and Science University, Portland, USA"},{"name":"Parkinson\u2019s Disease Research Education and Clinical Care Center, Portland VA Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000338632.00552.cb"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000180516.69442.95"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.3.387"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21956"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318253d54b"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.1274"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60492-X"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24045"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws318"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2013.849003"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0336-2"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.10.1353"},{"key":"e_1_3_3_14_2","first-page":"78549","article-title":"Gaucher disease and the Synucleinopathies","volume":"2006","author":"Hruska KS","year":"2006","unstructured":"Hruska KS, Goker-Alpan O, Sidransky E. Gaucher disease and the Synucleinopathies. J Biomed Biotechnol 2006; 2006: 78549.","journal-title":"J Biomed Biotechnol"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/89.9.691"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2001.3201"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0901281"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2015.1023436"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26359"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25248"},{"key":"e_1_3_3_21_2","first-page":"1048084","article-title":"The association between E326K of GBA and the risk of Parkinson\u2019s disease","author":"Huang Y","year":"2018","unstructured":"Huang Y, Deng L, Zhong Y, et al. The association between E326K of GBA and the risk of Parkinson\u2019s disease. Parkinsons Dis 2018; 2018: 1048084. 20180401.","journal-title":"Parkinsons Dis"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000104"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22687"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-023-09417-y"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00043"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29314"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.08.040"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq454"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06045-0"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2245"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.09.024"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12406"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12894"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02699-w"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae222"},{"key":"e_1_3_3_36_2","first-page":"773","article-title":"The GBA variant E326K is associated with alpha-Synuclein aggregation and lipid droplet accumulation in human cell lines","volume":"32","author":"Smith LJ","year":"2023","unstructured":"Smith LJ, Bolsinger MM, Chau KY, et al. The GBA variant E326K is associated with alpha-Synuclein aggregation and lipid droplet accumulation in human cell lines. Hum Mol Genet 2023; 32: 773\u2013789.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111443"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e318191c7dd"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004058"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0910-3"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-011-9589-0"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-007-0237-2"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.4.479"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2007.00117.x"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136767"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.07.008"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv179"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.06.001"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.057"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.10.001"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261468542","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261468542","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261468542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:14:24Z","timestamp":1789136064000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261468542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/1877718X261468542"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261468542","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}